Credit Suisse Ag Treace Medical Concepts, Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
A detailed history of Credit Suisse Ag transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 58,631 shares of TMCI stock, worth $388,723. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,631
Previous 58,391
0.41%
Holding current value
$388,723
Previous $744,000
2.82%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TMCI
# of Institutions
131Shares Held
40.8MCall Options Held
185KPut Options Held
37.1K-
Vanguard Group Inc Valley Forge, PA4.3MShares$28.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.7MShares$24.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.29MShares$21.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.4MShares$15.9 Million0.43% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.33MShares$15.4 Million0.08% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $367M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...